SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001513162-19-000071
Filing Date
2019-03-11
Accepted
2019-03-11 16:06:09
Documents
5
Effectiveness Date
2019-03-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a.htm DEFA14A 11236
2 GRAPHIC pg1.jpg GRAPHIC 222079
3 GRAPHIC pg2.jpg GRAPHIC 399628
4 GRAPHIC pg3.jpg GRAPHIC 139700
5 GRAPHIC pg4.jpg GRAPHIC 34345
  Complete submission text file 0001513162-19-000071.txt   1109011
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35285 | Film No.: 19672334
SIC: 2836 Biological Products, (No Diagnostic Substances)